(Q34057440)

30 July 2017

The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). (English)

1 reference

30 July 2017

0 references

Wiskott-Aldrich syndrome

1 reference

based on heuristic

inferred from title

United States of America

1 reference

Perry GS 3rd

1

1 reference

30 July 2017

Spector BD

2

1 reference

30 July 2017

Schuman LM

3

1 reference

30 July 2017

Mandel JS

4

1 reference

30 July 2017

Anderson VE

5

1 reference

30 July 2017

McHugh RB

6

1 reference

30 July 2017

Hanson MR

7

1 reference

30 July 2017

Fahlstrom SM

8

1 reference

30 July 2017

Krivit W

9

1 reference

30 July 2017

Kersey JH

10

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 1980

1 reference

The Journal of Pediatrics

30 July 2017

1 reference

30 July 2017

97

1 reference

30 July 2017

72-78

1 reference

30 July 2017

1

1 reference

Platelet Size and Kinetics in Hereditary and Acquired Thrombocytopenia

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Monocyte Receptors for Immunoglobulin and Complement in Immunologic Deficiency Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Nature of the platelet defect in the Wiskott-Aldrich syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Wiskott-Aldrich syndrome: detection of carrier state by metabolic stress of platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Fatal arteritis as a complication of Wiskott-Aldrich syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Risk of cancer in renal-transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

The development of malignancy in the course of the Aldrich syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Monoclonal gammopathy in the Wiskott-Aldrich syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

Complete Correction of the Wiskott-Aldrich Syndrome by Allogeneic Bone-Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980133-8

10.1016/S0022-3476(80)80133-8

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference